Tesamorelin is a stabilised analogue of growth-hormone-releasing hormone (GHRH) that prompts the pituitary to release the body’s own growth hormone in natural pulses.
Rather than supplying growth hormone directly, tesamorelin is a GHRH analogue: it signals the pituitary gland to produce and release endogenous growth hormone, preserving the body’s natural pulsatile rhythm.
It has been most studied for the reduction of excess visceral (deep abdominal) fat. Tesamorelin is the active ingredient in the FDA-approved product Egrifta, indicated for HIV-associated lipodystrophy.
Our pen is a pre-loaded 32 mg tesamorelin cartridge, third-party tested and cold-chain shipped.
Tesamorelin was assessed in randomised, placebo-controlled human trials for visceral adipose tissue (VAT) reduction, which supported its regulatory approval.
Trial and approval details describe the pharmaceutical compound in its studied indication; they are not a claim about this product.
Every batch is verified by an independent lab for identity and purity, with a downloadable certificate of analysis.
The pen ships ready to use. No reconstitution, no measuring, no vials.
Insulated shipping with a temperature indicator, dispatched within 24 hours.
Scan the QR on your pen or enter the batch number to see the exact certificate for your lot.
No. It is a GHRH analogue that prompts the body to release its own growth hormone, rather than adding synthetic HGH.
It has been studied mainly for reduction of visceral abdominal fat and is FDA-approved for HIV-associated lipodystrophy under the name Egrifta.
Yes — each batch is independently tested and the COA is downloadable on the product page.
A 32 mg pre-loaded pen with its batch certificate, shipped cold-chain across Europe.
In den Warenkorb — {total}Supplied for research and analytical purposes only. Not a medicine, not for human consumption, and not intended to diagnose, treat, cure or prevent any disease.
Wir verwenden Cookies für Analyse und Marketing, um Ihr Erlebnis zu verbessern. Sie können nicht notwendige Cookies annehmen oder ablehnen. Datenschutzerklärung